SELLAS Life Sciences Group, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.9M | $26.3M | $21.4M |
| FY2022 | $16.1M | $20.9M | $17.1M |
| FY2023 | $14.2M | $6.2M | $2.5M |
| FY2024 | $10.0M | $19.4M | $13.9M |
| FY2025 | $7.5M | $78.3M | $71.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.9M | $26.3M | $21.4M |
| FY2022 | $16.1M | $20.9M | $17.1M |
| FY2023 | $14.2M | $6.2M | $2.5M |
| FY2024 | $10.0M | $19.4M | $13.9M |
| FY2025 | $7.5M | $78.3M | $71.8M |